UWM Holdings reports Q2 results today with the stock at $1.84 — down another 5.6% on Wednesday — and the setup materially unchanged from yesterday's article: nearly 30% of the float sold short, options more defensive than at any point in the past year, and analysts pointing to a stock worth roughly twice the current price.
The options market is the freshest signal heading into the print. The put/call ratio jumped to 0.33 yesterday, more than two standard deviations above its 20-day average of 0.25 and the most defensive reading recorded over the past 52 weeks outside of one outlier spike. That shift has arrived in just the last three sessions — the PCR was running below 0.23 through most of July — suggesting traders moved quickly to hedge once the earnings date came into focus. The short position itself has barely budged: 29.7% of the free float is sold short, essentially flat on the week but up 31% over the past month. Availability remains at 61%, tighter than the 90%-plus levels that prevailed through most of July but not so constrained that new shorts face meaningful friction. Borrowing costs have edged up about 5% on the week to 1.54%, still modest in absolute terms.
The analyst community has been cutting targets steadily, even as ratings lean cautiously constructive. Morgan Stanley trimmed its target from $5.00 to $3.00 in late July while holding a neutral stance — a signal that even the sidelined view is coming down to earth. Barclays, still carrying an Overweight, cut its target to $4.00. The mean target across the coverage group now sits near $3.87, roughly 110% above the current price. That gap is the heart of the bull case: at 4.1x the 2027 earnings estimate and with $1.6 billion in tangible equity, bears may be getting paid well for a risk that is already widely understood. The bear case rests on the dividend — last paid in 2022, the prospect of a formal cut would remove one remaining pillar of support — alongside leverage concerns and the cash-flow drag from capitalising the MSR portfolio. The COO and Chief Strategy Officer both sold shares in May, and the CEO sold over $14 million worth across four consecutive days around the same period, a cluster that has not been offset by any subsequent buying.
The Q2 print is therefore less a referendum on whether UWM is under pressure — the market has priced in considerable pain at $1.84 — and more a test of whether origination volumes and margin can justify holding a dividend and balance sheet that analysts increasingly flag as unsustainable.
See the live data behind this article on ORTEX.
Open UWMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
